Denmark sells half a million vaccine doses to New Zealand

Denmark has agreed to sell half a million doses of the Pfizer vaccine to New Zealand, off-loading some of the surplus doses it purchased to make sure it would have enough to cover the entire population.

Denmark sells half a million vaccine doses to New Zealand
A video grab of New Zealand Prime Minister Jacinda Arden getting her first dose of the Pfizer vaccine back in June. Photo: Tvnz/Reuters/Ritzau Scanpix

In a press release issued on Sunday, Magnus Heunicke said the country would not need the doses even if it decided to give third booster doses.

“From the beginning, we have invested heavily in buying a wide range of vaccines for the Danish population,” he said.

“Today we have a surplus of mRNA vaccines that we do not need at home – even though we are faced with having to give people a third shot, and excess vaccines must, of course, go out and contribute to the global pandemic fight.”


The country’s prime minister Jacinda Ardern on Sunday thanked Denmark’s prime minister Mette Frederiksen “for the great cooperation” in a tweet.

Some 73.2 percent of the Danish population have now been fully vaccinated.

New Zealand has also bought surplus vaccine doses from Spain.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Covid-19: Danish research finds improved protection from updated vaccine

Denmark’s infectious disease control agency State Serum Institute (SSI) says that a second booster or “fourth dose” with an updated form of the Covid-19 vaccine will significantly improve protection against the virus.

Covid-19: Danish research finds improved protection from updated vaccine

The fourth dose will offer markedly better protection than if a person has only received a “third” dose or single booster jab, SSI said in a press statement.

SSI researchers, working with colleagues from the other Nordic countries, have analysed the effect of the additional booster jab with the vaccine, which has been updated in line with newer dominant subvariants of the coronavirus.

When the Danish population was first vaccinated against Covid-19, the vaccines were designed to offer protection against the original form of the virus, SSI writes.

But newer variants have made the original vaccines less effective. The updated vaccines are designed to have the best possible effect against both the original variant as well as the Omicron variant.

There are currently two versions of the updated vaccine. One is adapted towards the BA.1 Omicron subvariant, with another adapted to the BA.4-5 subvariant.

In the Nordic countries, the updated vaccines were offered during autumn 2022 to all persons over the age of 50 in Denmark and Sweden, over 60 in Finland and over 65 in Norway.

A fourth dose with the BA.1-updated version reduced the risk of hospitalisation with Covid-19 by 74 percent and the risk of death by 80 percent compared to the third dose, SSI found.

The BA.4-5 updated version reduced the risk of hospitalisation by 81 percent and the risk of death by 78 percent.

The latter of the two updated versions (BA.4-5) was found to reduce the risk of hospitalisation with Covid-19 by 32 percent compared to the BA-1 version.

“This is maybe not so surprising because BA.4-5 subvariants were dominant in autumn 2022,” SSI head of department Anders Hviid said in the statement.

“But I think we are among the first [countries] to be able to measure this based on the large quantities of data we have available from working across four countries,” he said.

The research was supported by the EU’s European Medicines Agency (EMA).

SSI notes that the frequency of hospitalisation and particularly death due to Covid-19 was very low after both the third and fourth doses of the vaccine.

The academic paper resulting from the study can be read in English here.

READ ALSO: Denmark’s health authority scraps isolation guidelines for Covid-19